Nelson Jao Lim M.D.

Hematology and Medical Oncology
Medical Team: Breast Cancer, Colo-Rectal Cancer, Lymphoma & Leukemia, Intensive Care

Current Title

  • Attending Physician, Division of Hematology and Medical Oncology, 2009-present


  • Hematology and Medical Oncology 

Clinical Interests

  • Colorectal cancer
  • Breast cancer
  • Hepatobiliary & Upper Gastrointestinal cancer

Languages Spoken

  • Mandarin Chinese
  • English
  • Taiwanese

Education and Training

1987 University of the Philippines, Diliman, Quezon City, Philippines, BS, Biology
1991 University of the East Ramon Magsaysay Memorial Medical Center College of Medicine, Quezon City, Philippine, MD, Medicine
5/1991-4/1992 Rotating Internship, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines
7/1994-6/1997 Residency, University of Connecticut Program; University of Connecticut Health Center, Farmington, CT, USA; Hartford Hospital, Hartford, CT, USA; Saint Francis Hospital and Medical Center, Hartford, CT, USA; Veterans Affairs Medical Center, Newington, CT, USA    
7/1997-6/2000 Fellowship, University of California Davis Medical Center Program, Sacramento, CA, USA

Professional Experience

7/1999-6/2000 Attending Physician, Hematology and Oncology, San Joaquin General Hospital, French Camp, CA, USA
2/2001- 9/2006

Attending Physician, Hematology and Oncology, Veterans Affairs Northern California Health Care System, VA Medical Center, Sacramento, CA and Martinez, CA, USA

8/2001-9/2006 Attending Physician, Hematology and Oncology, Contra Costa Regional Medical Center, Martinez, CA, USA

Attending Physician, Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan

Professional Memberships

  • Clinical Researcher, Southwest Oncology Group
  • Clinical Researcher, National Cancer Institute
  • American Board of Internal Medicine, Internal Medicine, 1997
  • American Board of Internal Medicine, Oncology, 2000
  • American Board of Internal Medicine, Hematology, 2000

Selected Publications

  1. Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment. Primo N. Lara, Jr, Roger Higdon, Nelson Lim, Karen Kwan, Michael Tanaka, Derick H.M. Lau, Ted Wun, Jeanna Welborn, Frederick J. Meyers, Scott Christensen, Robert O'Donnell, Carol Richman, Sidney A. Scudder, Joseph Tuscano, David R. Gandara, Kit S. Lam. JCO Mar 15 2001: 1728-1733.
  2. Novel 21-Day Schedule of Gemcitabine (GEM) and Paclitaxel (TAX) in Advanced Solid Tumors: Final Results of a Phase I Trial. Nelson Lim, Primo Lara, Martin Edelman, Derick Lau, Michael Tanaka, Joan Houston, Ignacio Lauder, David Gandara. Proc Am Soc Cli Oncol 19:2000 ( abstract 915)
Copyright © Koo Foundation Sun Yat-Sen Cancer Center 125 Lih-Der Road, Pei-Tou District, Taipei, Taiwan. Tel:+886 2 2897-0011